RFG - Bristol Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
HCM
FWCM
MSV
AIM
EB
SC
AP
IWA
MPWT
FFA
RFG - Bristol Wealth Advisors's ABBV Position: Q3 2026 in Review
RFG - Bristol Wealth Advisors increased its AbbVie (ABBV) stake by 0.2% in Q3 2026, buying an estimated $2.31K and bringing the position to 4,541 shares worth $1.19M. The position accounts for 0.28% of the portfolio, ranked #68.
RFG - Bristol Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- RFG - Bristol Wealth Advisors held 4,541 shares of AbbVie worth $1.19M as of Q3 2026.
- RFG - Bristol Wealth Advisors bought 9 AbbVie shares in Q3 2026, an estimated $2.31K.
- AbbVie made up 0.28% of RFG - Bristol Wealth Advisors's portfolio in Q3 2026, its #68 holding.
- RFG - Bristol Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on RFG - Bristol Wealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.